Trial | NCT00382577  Report issue

Title

Efficacy and Safety of Itopride vs Placebo in Heartburn
A Randomized, Double-blind, Two Period, Crossover Study to Evaluate the Effects of a Single Dose of Itopride 200 mg on Esophageal and Gastric pH and Reflux in Patients With Heartburn

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    itropride ...

  • Study Participants

    48
The purpose of this study is to evaluate the effects of itopride in patients with heartburn.
Study Started
Oct 31
2006
Study Completion
Dec 31
2006
Last Update
Feb 09
2017
Estimate

Drug Itopride

Drug Placebo

Criteria 

Inclusion Criteria:

Otherwise healthy males and females aged 18-70, with at least 3 episodes of heartburn or acid regurgitation per week.
No Results Posted